Page last updated: 2024-10-24

verapamil and Aging

verapamil has been researched along with Aging in 97 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.

Research Excerpts

ExcerptRelevanceReference
" In young Dahl/S rats, an angiotensin-converting enzyme inhibitor, imidapril, attenuated the development of proteinuria accompanied by a decrease in blood pressure."7.70Involvement of angiotensin II in development of spontaneous nephrosis in Dahl salt-sensitive rats. ( Fujimura, H; Nishiyama, S; Ohmachi, Y; Okumura, F; Toriumi, W; Yoneda, H, 1998)
"Aging decreases elimination of racemic verapamil but reports vary regarding effects of aging on clearance of individual verapamil enantiomers."7.69Verapamil stereoisomers during racemic verapamil administration: effects of aging and comparisons to administration of individual stereoisomers. ( Capili, H; Schwartz, JB; Wainer, IW, 1994)
" Allosteric modulation of [3H]-NTP binding by the phenylalkylamine, verapamil and the benzothiazepine, diltiazem were preserved in aging heart."7.68Density of 1,4-dihydropyridine receptors decreases in the hearts of aging hamsters. ( Howlett, SE; Nicholl, PA, 1992)
"The effects of aging on heart rate and atrioventricular (AV) conduction responses to verapamil (0-100 ng/ml) were studied in Langendorff perfused hearts from 12 mature (4-6 months) and 12 senescent (24 months) male Fischer 344 rats and in hearts from 10 mature and 9 senescent rats after reserpine administration (0."7.68The effects of aging on the electrophysiologic responses to verapamil in isolated perfused rat hearts. ( Garcia, J; Schmidlin, O; Schwartz, JB, 1991)
"This study investigated the cardiac responses and pharmacokinetics following the acute and chronic administration of verapamil in 14 middle-aged and elderly patients with ischemic heart disease (age range 42-76 years)."6.67Low-dose verapamil in middle-aged and elderly patients with angina pectoris: no evidence of increased susceptibility to the cardiac effects. ( Ahmed, JH; Elliott, HL; Meredith, PA; Reid, JL, 1992)
"0004) and elimination half-life values increased in an age-related manner from 347 +/- 97 minutes in young women to 453 +/- 153 minutes in elderly women (p < 0."5.29Aging of women alters S-verapamil pharmacokinetics and pharmacodynamics. ( Capili, H; Daugherty, J; Schwartz, JB, 1994)
"Verapamil clearance was found to be decreased in an age-related stereoselective manner, with significant reductions in l-verapamil clearance in older subjects (P < ."5.29Aging effects on stereoselective pharmacokinetics and pharmacodynamics of verapamil. ( Capili, H; Liu, S; Schwartz, JB; Troconiz, IF; Verotta, D, 1993)
"Increased V (T) of (R)-[(11)C]verapamil with aging was found in several large brain regions in men."5.16P-glycoprotein function at the blood-brain barrier: effects of age and gender. ( Boellaard, R; Lammertsma, AA; Lubberink, M; Scheltens, P; Schuit, RC; van Assema, DM; van Berckel, BN; Windhorst, AD, 2012)
" In young Dahl/S rats, an angiotensin-converting enzyme inhibitor, imidapril, attenuated the development of proteinuria accompanied by a decrease in blood pressure."3.70Involvement of angiotensin II in development of spontaneous nephrosis in Dahl salt-sensitive rats. ( Fujimura, H; Nishiyama, S; Ohmachi, Y; Okumura, F; Toriumi, W; Yoneda, H, 1998)
" Allosteric modulation of [3H]-NTP binding by the phenylalkylamine, verapamil and the benzothiazepine, diltiazem were preserved in aging heart."3.68Density of 1,4-dihydropyridine receptors decreases in the hearts of aging hamsters. ( Howlett, SE; Nicholl, PA, 1992)
"The influence of age on the pharmacokinetics of verapamil at steady state has been studied in 74 individuals, age range 19-79 years, including healthy normotensive volunteers and patients with essential hypertension."3.68The influence of age on the pharmacokinetics of verapamil. ( Ahmed, JH; Elliott, HL; Meredith, PA, 1991)
"The effects of aging on heart rate and atrioventricular (AV) conduction responses to verapamil (0-100 ng/ml) were studied in Langendorff perfused hearts from 12 mature (4-6 months) and 12 senescent (24 months) male Fischer 344 rats and in hearts from 10 mature and 9 senescent rats after reserpine administration (0."3.68The effects of aging on the electrophysiologic responses to verapamil in isolated perfused rat hearts. ( Garcia, J; Schmidlin, O; Schwartz, JB, 1991)
"We have previously described a method for inducing atrial ectopic tachycardia (AET) in the anesthetized adult rat using digoxin, 30 mg/kg s."3.67Age-related digoxin-verapamil interactions in the adult rat. ( Jarenwattananon, M; Kaplanski, J; Nudel, DB; Weinhouse, E, 1989)
" Calcium antagonists, including verapamil, are now used widely in the management of patients with hypertension."3.67Calcium antagonists and hypertension. ( Dillon, JS; Nayler, WG; Sturrock, WJ, 1988)
"It is now recognized that left ventricular hypertrophy (LVH), often associated with hypertension, is itself a risk factor for coronary disease in the elderly."2.67Left ventricular mass regression in elderly hypertensives. ( Gerstenblith, G, 1992)
"This study investigated the cardiac responses and pharmacokinetics following the acute and chronic administration of verapamil in 14 middle-aged and elderly patients with ischemic heart disease (age range 42-76 years)."2.67Low-dose verapamil in middle-aged and elderly patients with angina pectoris: no evidence of increased susceptibility to the cardiac effects. ( Ahmed, JH; Elliott, HL; Meredith, PA; Reid, JL, 1992)
" Pharmacokinetic parameters obtained after oral administration were not significantly different from those after intravenous dosing."2.65Pharmacokinetics of calcium blockers in patients with renal insufficiency and in geriatric patients. ( Larsen, A; Midtbø, K; Saevareid, L; Storstein, L, 1984)
" The efficacy of MMF as an immunosuppressant and long-term safety in cats of this dosage regimen is unknown."2.61 ( Abrams, G; Adolfsson, E; Agarwal, PK; Akkan, AG; Al Alhareth, NS; Alves, VGL; Armentano, R; Bahroos, E; Baig, M; Baldridge, KK; Barman, S; Bartolucci, C; Basit, A; Bertoli, SV; Bian, L; Bigatti, G; Bobenko, AI; Boix, PP; Bokulic, T; Bolink, HJ; Borowiec, J; Bulski, W; Burciaga, J; Butt, NS; Cai, AL; Campos, AM; Cao, G; Cao, Y; Čapo, I; Caruso, ML; Chao, CT; Cheatum, CM; Chelminski, K; Chen, AJW; Chen, C; Chen, CH; Chen, D; Chen, G; Chen, H; Chen, LH; Chen, R; Chen, RX; Chen, X; Cherdtrakulkiat, R; Chirvony, VS; Cho, JG; Chu, K; Ciurlino, D; Coletta, S; Contaldo, G; Crispi, F; Cui, JF; D'Esposito, M; de Biase, S; Demir, B; Deng, W; Deng, Z; Di Pinto, F; Domenech-Ximenos, B; Dong, G; Drácz, L; Du, XJ; Duan, LJ; Duan, Y; Ekendahl, D; Fan, W; Fang, L; Feng, C; Followill, DS; Foreman, SC; Fortunato, G; Frew, R; Fu, M; Gaál, V; Ganzevoort, W; Gao, DM; Gao, X; Gao, ZW; Garcia-Alvarez, A; Garza, MS; Gauthier, L; Gazzaz, ZJ; Ge, RS; Geng, Y; Genovesi, S; Geoffroy, V; Georg, D; Gigli, GL; Gong, J; Gong, Q; Groeneveld, J; Guerra, V; Guo, Q; Guo, X; Güttinger, R; Guyo, U; Haldar, J; Han, DS; Han, S; Hao, W; Hayman, A; He, D; Heidari, A; Heller, S; Ho, CT; Ho, SL; Hong, SN; Hou, YJ; Hu, D; Hu, X; Hu, ZY; Huang, JW; Huang, KC; Huang, Q; Huang, T; Hwang, JK; Izewska, J; Jablonski, CL; Jameel, T; Jeong, HK; Ji, J; Jia, Z; Jiang, W; Jiang, Y; Kalumpha, M; Kang, JH; Kazantsev, P; Kazemier, BM; Kebede, B; Khan, SA; Kiss, J; Kohen, A; Kolbenheyer, E; Konai, MM; Koniarova, I; Kornblith, E; Krawetz, RJ; Kreouzis, T; Kry, SF; Laepple, T; Lalošević, D; Lan, Y; Lawung, R; Lechner, W; Lee, KH; Lee, YH; Leonard, C; Li, C; Li, CF; Li, CM; Li, F; Li, J; Li, L; Li, S; Li, X; Li, Y; Li, YB; Li, Z; Liang, C; Lin, J; Lin, XH; Ling, M; Link, TM; Liu, HH; Liu, J; Liu, M; Liu, W; Liu, YP; Lou, H; Lu, G; Lu, M; Lun, SM; Ma, Z; Mackensen, A; Majumdar, S; Martineau, C; Martínez-Pastor, JP; McQuaid, JR; Mehrabian, H; Meng, Y; Miao, T; Miljković, D; Mo, J; Mohamed, HSH; Mohtadi, M; Mol, BWJ; Moosavi, L; Mosdósi, B; Nabu, S; Nava, E; Ni, L; Novakovic-Agopian, T; Nyamunda, BC; Nyul, Z; Önal, B; Özen, D; Özyazgan, S; Pajkrt, E; Palazon, F; Park, HW; Patai, Á; Patai, ÁV; Patzke, GR; Payette, G; Pedoia, V; Peelen, MJCS; Pellitteri, G; Peng, J; Perea, RJ; Pérez-Del-Rey, D; Popović, DJ; Popović, JK; Popović, KJ; Posecion, L; Povall, J; Prachayasittikul, S; Prachayasittikul, V; Prat-González, S; Qi, B; Qu, B; Rakshit, S; Ravelli, ACJ; Ren, ZG; Rivera, SM; Salo, P; Samaddar, S; Samper, JLA; Samy El Gendy, NM; Schmitt, N; Sekerbayev, KS; Sepúlveda-Martínez, Á; Sessolo, M; Severi, S; Sha, Y; Shen, FF; Shen, X; Shen, Y; Singh, P; Sinthupoom, N; Siri, S; Sitges, M; Slovak, JE; Solymosi, N; Song, H; Song, J; Song, M; Spingler, B; Stewart, I; Su, BL; Su, JF; Suming, L; Sun, JX; Tantimavanich, S; Tashkandi, JM; Taurbayev, TI; Tedgren, AC; Tenhunen, M; Thwaites, DI; Tibrewala, R; Tomsejm, M; Triana, CA; Vakira, FM; Valdez, M; Valente, M; Valentini, AM; Van de Winckel, A; van der Lee, R; Varga, F; Varga, M; Villarino, NF; Villemur, R; Vinatha, SP; Vincenti, A; Voskamp, BJ; Wang, B; Wang, C; Wang, H; Wang, HT; Wang, J; Wang, M; Wang, N; Wang, NC; Wang, Q; Wang, S; Wang, X; Wang, Y; Wang, Z; Wen, N; Wesolowska, P; Willis, M; Wu, C; Wu, D; Wu, L; Wu, X; Wu, Z; Xia, JM; Xia, X; Xia, Y; Xiao, J; Xiao, Y; Xie, CL; Xie, LM; Xie, S; Xing, Z; Xu, C; Xu, J; Yan, D; Yan, K; Yang, S; Yang, X; Yang, XW; Ye, M; Yin, Z; Yoon, N; Yoon, Y; Yu, H; Yu, K; Yu, ZY; Zhang, B; Zhang, GY; Zhang, H; Zhang, J; Zhang, M; Zhang, Q; Zhang, S; Zhang, W; Zhang, X; Zhang, Y; Zhang, YW; Zhang, Z; Zhao, D; Zhao, F; Zhao, P; Zhao, W; Zhao, Z; Zheng, C; Zhi, D; Zhou, C; Zhou, FY; Zhu, D; Zhu, J; Zhu, Q; Zinyama, NP; Zou, M; Zou, Z, 2019)
" Concomitant intake of rifampicin (600 mg/die) induced especially the presystemic (prehepatic) metabolism of verapamil so that oral bioavailability approached zero and PD effects almost diminished."2.40Effect of age on pharmacokinetics and pharmacodynamics in man. ( Klotz, U, 1998)
" Nevertheless, this procedure may provide useful information for optimizing the dosage regimen of each patient as the pathological condition and drug therapy may be quite complex."2.37Pharmacokinetics of diltiazem and other calcium entry blockers. ( Hermann, P; Morselli, PL, 1985)
" The bioavailability of diltiazem and nifedipine has not been well studied, and no investigations of the absolute bioavailability of these compounds have been reported."2.36Calcium antagonists. Pharmacokinetic properties. ( Kates, RE, 1983)
"Oral treatment with verapamil or vehicle was started, 24 h post-intracerebroventricular (ICV) streptozotocin/(STZ), in 12-month-old animals and continued for 3 months."1.62Verapamil Prevents Development of Cognitive Impairment in an Aged Mouse Model of Sporadic Alzheimer's Disease. ( Ahmed, HA; Ishrat, T; Ismael, S; Mirzahosseini, G, 2021)
" Other pharmacokinetic parameters, such as volume of distribution and plasma protein binding did not show any statistical differences."1.31Pharmacokinetics of verapamil in New Zealand white rabbits during ontogeny. ( Aramayona, JJ; Bregante, MA; Fraile, LJ; Garcia, MA; Solans, C, 2000)
"Verapamil was added to pre- and post-smoking blood samples to yield a final concentration of 1 mg-1."1.29Effect of acute smoking on red blood cell deformability in healthy young and elderly non-smokers, and effect of verapamil on age- and acute smoking-induced change in red blood cell deformability. ( Salbaş, K, 1994)
"Verapamil disposition was also age related."1.27Verapamil pharmacodynamics and disposition in young and elderly hypertensive patients. Altered electrocardiographic and hypotensive responses. ( Abernethy, DR; Luchi, R; Schwartz, JB; Snow, E; Todd, EL, 1986)
" Therefore, even though there is little variation in the pharmacokinetic parameters between adult dogs and puppies, there is a marked reduction in the sensitivity of the puppies to the ECG effects of verapamil."1.27Age-related changes in the pharmacodynamics of verapamil. ( Arnold, TH; Tackett, RL; Vallner, JJ, 1985)
"Norverapamil was measured in plasma after oral dosing, but was not detectable after intravenous dosing."1.26Prediction of steady-state verapamil plasma concentrations in children and adults. ( Rocchini, AP; Vasiliades, J; Wagner, JG, 1982)
"Verapamil has been studied extensively in adult animals."1.26The comparative electrophysiologic and hemodynamic effects of verapamil in puppies and adult dogs. ( Driscoll, D; Entman, ML; Gibson, R; Gillette, P; Hartley, C, 1981)

Research

Studies (97)

TimeframeStudies, this research(%)All Research%
pre-199036 (37.11)18.7374
1990's42 (43.30)18.2507
2000's10 (10.31)29.6817
2010's8 (8.25)24.3611
2020's1 (1.03)2.80

Authors

AuthorsStudies
Bobenko, AI1
Heller, S1
Schmitt, N1
Cherdtrakulkiat, R1
Lawung, R1
Nabu, S1
Tantimavanich, S1
Sinthupoom, N1
Prachayasittikul, S1
Prachayasittikul, V1
Zhang, B1
Wu, C1
Zhang, Z2
Yan, K1
Li, C2
Li, Y4
Li, L3
Zheng, C1
Xiao, Y1
He, D1
Zhao, F1
Su, JF1
Lun, SM1
Hou, YJ1
Duan, LJ1
Wang, NC1
Shen, FF1
Zhang, YW1
Gao, ZW1
Li, J5
Du, XJ1
Zhou, FY1
Yin, Z1
Zhu, J2
Yan, D1
Lou, H1
Yu, H1
Feng, C1
Wang, Z1
Wang, Y4
Hu, X1
Li, Z2
Shen, Y2
Hu, D1
Chen, H1
Wu, X1
Duan, Y1
Zhi, D1
Zou, M2
Zhao, Z1
Zhang, X2
Yang, X2
Zhang, J2
Wang, H1
Popović, KJ1
Popović, DJ1
Miljković, D1
Lalošević, D1
Čapo, I1
Popović, JK1
Liu, M1
Song, H2
Xing, Z1
Lu, G1
Chen, D1
Valentini, AM1
Di Pinto, F1
Coletta, S1
Guerra, V1
Armentano, R1
Caruso, ML1
Gong, J1
Wang, N1
Bian, L1
Wang, M1
Ye, M1
Wen, N1
Fu, M1
Fan, W1
Meng, Y1
Dong, G1
Lin, XH1
Liu, HH1
Gao, DM1
Cui, JF1
Ren, ZG1
Chen, RX1
Önal, B1
Özen, D1
Demir, B1
Akkan, AG1
Özyazgan, S1
Payette, G1
Geoffroy, V1
Martineau, C1
Villemur, R1
Jameel, T1
Baig, M1
Gazzaz, ZJ1
Tashkandi, JM1
Al Alhareth, NS1
Khan, SA1
Butt, NS1
Wang, J2
Geng, Y1
Zhang, Y3
Wang, X2
Liu, J2
Basit, A1
Miao, T1
Liu, W1
Jiang, W1
Yu, ZY1
Wu, L2
Qu, B1
Sun, JX1
Cai, AL1
Xie, LM1
Groeneveld, J1
Ho, SL1
Mackensen, A1
Mohtadi, M1
Laepple, T1
Genovesi, S1
Nava, E1
Bartolucci, C1
Severi, S1
Vincenti, A1
Contaldo, G1
Bigatti, G1
Ciurlino, D1
Bertoli, SV1
Slovak, JE1
Hwang, JK1
Rivera, SM1
Villarino, NF1
Li, S1
Cao, G1
Ling, M1
Ji, J1
Zhao, D1
Sha, Y1
Gao, X1
Liang, C2
Guo, Q1
Zhou, C1
Ma, Z1
Xu, J1
Wang, C1
Zhao, W1
Xia, X1
Jiang, Y1
Peng, J1
Jia, Z1
Li, F1
Chen, X2
Mo, J1
Zhang, S2
Li, X1
Huang, T1
Zhu, Q1
Wang, S1
Ge, RS1
Fortunato, G1
Lin, J2
Agarwal, PK1
Kohen, A1
Singh, P1
Cheatum, CM1
Zhu, D1
Hayman, A1
Kebede, B1
Stewart, I1
Chen, G1
Frew, R1
Guo, X1
Gong, Q1
Borowiec, J1
Han, S1
Zhang, M1
Willis, M1
Kreouzis, T1
Yu, K1
Chirvony, VS1
Sekerbayev, KS1
Pérez-Del-Rey, D1
Martínez-Pastor, JP1
Palazon, F1
Boix, PP1
Taurbayev, TI1
Sessolo, M1
Bolink, HJ1
Lu, M1
Lan, Y1
Xiao, J1
Song, M1
Chen, C1
Huang, Q1
Cao, Y1
Ho, CT1
Qi, B1
Wang, Q1
Zhang, W1
Fang, L1
Xie, CL1
Chen, R1
Yang, S1
Xia, JM1
Zhang, GY1
Chen, CH1
Yang, XW1
Domenech-Ximenos, B1
Garza, MS1
Prat-González, S1
Sepúlveda-Martínez, Á1
Crispi, F1
Perea, RJ1
Garcia-Alvarez, A1
Sitges, M1
Kalumpha, M1
Guyo, U1
Zinyama, NP1
Vakira, FM1
Nyamunda, BC1
Varga, M1
Drácz, L1
Kolbenheyer, E1
Varga, F1
Patai, ÁV1
Solymosi, N1
Patai, Á1
Kiss, J1
Gaál, V1
Nyul, Z1
Mosdósi, B1
Valdez, M1
Moosavi, L1
Heidari, A1
Novakovic-Agopian, T1
Kornblith, E1
Abrams, G1
McQuaid, JR1
Posecion, L1
Burciaga, J1
D'Esposito, M1
Chen, AJW1
Samy El Gendy, NM1
Wesolowska, P1
Georg, D1
Lechner, W1
Kazantsev, P1
Bokulic, T1
Tedgren, AC1
Adolfsson, E1
Campos, AM1
Alves, VGL1
Suming, L1
Hao, W1
Ekendahl, D1
Koniarova, I1
Bulski, W1
Chelminski, K1
Samper, JLA1
Vinatha, SP1
Rakshit, S1
Siri, S1
Tomsejm, M1
Tenhunen, M1
Povall, J1
Kry, SF1
Followill, DS1
Thwaites, DI1
Izewska, J1
Kang, JH1
Yoon, Y1
Song, J1
Van de Winckel, A1
Gauthier, L1
Chao, CT1
Lee, YH1
Li, CM1
Han, DS1
Huang, JW1
Huang, KC1
Ni, L1
Güttinger, R1
Triana, CA1
Spingler, B1
Baldridge, KK1
Patzke, GR1
Shen, X1
Wang, B1
Xie, S1
Deng, W1
Wu, D1
Zhang, Q1
Voskamp, BJ1
Peelen, MJCS1
Ravelli, ACJ1
van der Lee, R1
Mol, BWJ1
Pajkrt, E1
Ganzevoort, W1
Kazemier, BM1
Tibrewala, R1
Bahroos, E1
Mehrabian, H1
Foreman, SC1
Link, TM1
Pedoia, V1
Majumdar, S1
Jablonski, CL1
Leonard, C1
Salo, P1
Krawetz, RJ1
Yoon, N1
Hong, SN1
Cho, JG1
Jeong, HK1
Lee, KH1
Park, HW1
Barman, S1
Konai, MM1
Samaddar, S1
Haldar, J1
Mohamed, HSH1
Li, CF1
Hu, ZY1
Deng, Z1
Chen, LH1
Su, BL1
Chu, K1
Liu, YP1
Li, YB1
Zhang, H1
Xu, C1
Zou, Z1
Wu, Z1
Xia, Y1
Zhao, P1
Wang, HT1
de Biase, S1
Pellitteri, G1
Gigli, GL1
Valente, M1
Kim, JM1
Heo, HS1
Shin, SC1
Kwon, HK1
Lee, JC1
Sung, ES1
Kim, HS1
Park, GC1
Lee, BJ1
Ahmed, HA1
Ismael, S1
Mirzahosseini, G1
Ishrat, T1
Zefirov, TL1
Kuptsova, AM1
Biktemirova, RG1
Ziyatdinova, NI1
Zefirov, AL1
Bauer, M1
Karch, R1
Neumann, F1
Abrahim, A1
Wagner, CC1
Kletter, K1
Müller, M1
Zeitlinger, M1
Langer, O1
Salameh, A1
Dhein, S1
Fleischmann, B1
Grohe, C1
Hescheler, J1
Linz, KW1
Meyer, R1
Lewin, G1
Hoymann, HG1
Fuhst, R1
Berger-Preiss, E1
Pohlmann, G1
Buschmann, J1
Bartels, AL2
de Klerk, OL2
Kortekaas, R2
de Vries, JJ2
Leenders, KL2
Takashima, T1
Yokoyama, C1
Mizuma, H1
Yamanaka, H1
Wada, Y1
Onoe, K1
Nagata, H1
Tazawa, S1
Doi, H1
Takahashi, K1
Morita, M1
Kanai, M1
Shibasaki, M1
Kusuhara, H1
Sugiyama, Y1
Onoe, H1
Watanabe, Y1
van Assema, DM1
Lubberink, M2
Boellaard, R1
Schuit, RC1
Windhorst, AD1
Scheltens, P1
Lammertsma, AA2
van Berckel, BN2
Calado, RT1
Machado, CG1
Carneiro, JJ1
Garcia, AB1
Falcão, RP1
Toornvliet, R1
Luurtsema, G1
Geldof, AA1
Bosch, TM1
Oerlemans, R1
Franssen, EJ1
Poindexter, BJ1
Feng, W1
Dasgupta, A1
Bick, RJ1
Bart, J1
Willemsen, AT1
van Oostrom, JC1
Boucek, RJ1
Shelton, M1
Artman, M1
Mushlin, PS1
Starnes, VA1
Olson, RD1
Manoach, M1
Netz, H1
Erez, M1
Weinstock, M1
Hulthén, UL1
Bolli, P1
Bühler, FR1
Kates, RE1
Kuo, TH1
Ho, KL1
Wiener, J1
Storstein, L1
Larsen, A1
Midtbø, K1
Saevareid, L1
Tonoue, T1
Furukawa, K1
Nomoto, T1
Kennes, B1
Hubert, C1
Brohee, D1
Neve, P1
Wagner, JG1
Rocchini, AP1
Vasiliades, J1
Reder, RF2
Miura, DS1
Danilo, P2
Rosen, MR2
Gibson, R1
Driscoll, D1
Gillette, P1
Hartley, C1
Entman, ML1
Wong, RO1
Piovan, D2
Padrini, R2
Svalato Moreolo, G1
Magnolfi, G1
Milanesi, O1
Zordan, R1
Pellegrino, PA1
Ferrari, M2
Salbaş, K1
Reams, GP1
Monsuez, JJ1
Lachurie, ML1
Passeron, J1
Schwartz, JB8
Shen, C1
Garcia, J2
Capili, H4
Sniezek, M1
Ragazzi, E1
Chinellato, A1
Pandolfo, L1
Froldi, G1
Caparrotta, L1
Fassina, G1
Wainer, IW3
Arrighi, JA1
Dilsizian, V1
Perrone-Filardi, P1
Diodati, JG1
Bacharach, SL1
Bonow, RO2
Daugherty, J1
Fraeyman, N1
van Ermen, A1
Witkowski, JM1
Acanfora, D1
De Caprio, L1
Di Palma, A1
Lirato, C1
Parlati, S1
Furgi, G1
Guerra, N1
Odierna, L1
Nicolino, A1
Rengo, F3
Abernethy, DR3
Longstreth, JA1
Andrawis, NS1
Sasaki, M1
Tateishi, T1
Ebihara, A1
Ostádalová, I1
Kolár, F1
Ostádal, B2
Rohlícek, V1
Rohlícek, J1
Procházka, J2
Troconiz, IF1
Verotta, D1
Liu, S1
Cyran, SE1
Phillips, J1
Ditty, S1
Baylen, BG1
Cheung, J1
LaNoue, K1
Roder, JD1
Sangiah, S1
Bauer, LA1
Horn, JR1
Pettit, H1
Vitale, DF1
Calabrò, R1
De Cristofaro, M1
Pacileo, G1
Caso, P1
Gerundo, G1
Bordini, C1
Losi, MA1
Rengo, C1
Audsley, N1
Goldsworthy, GJ1
Coast, GM1
Fromm, MF1
Dilger, K1
Busse, D1
Kroemer, HK1
Eichelbaum, M1
Klotz, U2
Doggrell, SA1
Liang, LC1
Yoneda, H1
Toriumi, W1
Ohmachi, Y1
Okumura, F1
Fujimura, H1
Nishiyama, S1
Petrella, RJ2
Cunningham, DA2
Paterson, DH2
Anacleto, AI1
Solans, C1
Bregante, MA1
Aramayona, JJ1
Fraile, LJ1
Garcia, MA1
Nair, RR1
Nair, P1
Hung, MJ1
Cherng, WJ1
Wang, CH1
Kuo, LT1
Hordof, AJ1
Davies, M1
Gerstenblith, G2
Howlett, SE1
Nicholl, PA1
Ahmed, JH2
Elliott, HL2
Meredith, PA3
Reid, JL1
Kirischuk, S1
Pronchuk, N1
Verkhratsky, A1
Smeda, JS1
Abete, P1
Ferrara, N1
Leosco, D1
Caccese, P1
Landino, P1
Sederino, S1
Balbi, R1
Le Couteur, D1
Rivory, LP1
Roberts, MS1
Pond, SM1
Barringer, DL1
Buñag, RD1
Andrushchenko, EV1
Chmir, VP1
Krasovskaia, EA1
Malanchuk, TA1
Polishchuk, II1
Iashchenko, OB1
McCue, JD1
Schmidlin, O1
Pepeu, G2
Giovannelli, L2
Battaini, F1
Govoni, S1
Rius, RA1
Trabucchi, M1
Vermue, NA1
Den Hertog, A1
Draznin, B1
Sussman, KE1
Kao, M1
Sherman, N1
Böhmer, F1
Barousch, R1
Reinfrank, J1
Gómez Pajuelo, C1
Pérez Naranjo, J1
Ruiz Martínez, I1
Hosie, J1
Hosie, G1
Dillon, JS2
Gu, XH1
Nayler, WG2
Carosella, L1
Menichelli, P1
Alimenti, M1
Zuccala, G1
Gemma, A1
Cocchi, A1
Carbonin, PU1
Weinhouse, E1
Kaplanski, J1
Jarenwattananon, M2
Nudel, DB1
Sturrock, WJ1
Oja, SS1
Kontro, P1
Lauterburg, BH1
Carvajal, A2
Franganillo, AM2
Alvarez, FJ2
Bova, S1
Moretto, R1
Cargnelli, G1
Buckley, BJ1
Gootman, N1
Kaplan, NA1
Todd, EL1
Luchi, R1
Snow, E1
Skovránek, J1
Pelouch, V1
Hermann, P1
Morselli, PL1
Karaki, H1
Nakagawa, H1
Urakawa, N1
Arnold, TH1
Vallner, JJ1
Tackett, RL1
Sotobata, I1
Yamauchi, K1
Tsuzuki, M1
Noda, S1
Hatano, K1
Ito, E1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
CID 0708 - Sex, Aging and Antiretroviral Pharmacokinetics[NCT00666055]11 participants (Actual)Observational2008-03-31Completed
Myocardial Ultrasonic Tissue Characterization in Patients With a Genetic Predisposition for the Development of Hypertrophic Cardiomyopathy[NCT00001632]195 participants Observational1997-09-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

8 reviews available for verapamil and Aging

ArticleYear
    Proceedings. Mathematical, physical, and engineering sciences, 2019, Volume: 475, Issue:2227

    Topics: Acetylcholine; Acinetobacter baumannii; Actinobacteria; Action Potentials; Adalimumab; Adaptation, P

2019
11C-verapamil to assess P-gp function in human brain during aging, depression and neurodegenerative disease.
    Current topics in medicinal chemistry, 2010, Volume: 10, Issue:17

    Topics: Aging; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain Diseases;

2010
Calcium influx blockers in the treatment of essential hypertension.
    Acta medica Scandinavica. Supplementum, 1984, Volume: 681

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Aging; Animals; Drug Therapy, Combination; Forearm; Humans

1984
Calcium antagonists. Pharmacokinetic properties.
    Drugs, 1983, Volume: 25, Issue:2

    Topics: Administration, Oral; Aging; Biological Availability; Calcium Channel Blockers; Chemical Phenomena;

1983
Do calcium channel blockers have renal protective effects?
    Drugs & aging, 1994, Volume: 5, Issue:4

    Topics: Aging; Animals; Calcium Channel Blockers; Clinical Trials as Topic; Cyclosporine; Diabetic Nephropat

1994
Effect of age on pharmacokinetics and pharmacodynamics in man.
    International journal of clinical pharmacology and therapeutics, 1998, Volume: 36, Issue:11

    Topics: Adolescent; Adult; Aged; Aging; Anti-Anxiety Agents; Area Under Curve; Calcium Channel Blockers; Hum

1998
Drug interchanges at the pharmacy: safe for cardiovascular disease?
    Hospital practice (Office ed.), 1991, Jul-15, Volume: 26, Issue:7

    Topics: Aging; Biological Availability; Delayed-Action Preparations; Gastrointestinal Motility; Humans; Hydr

1991
Pharmacokinetics of diltiazem and other calcium entry blockers.
    Acta pharmacologica et toxicologica, 1985, Volume: 57 Suppl 2

    Topics: Administration, Oral; Adult; Aged; Aging; Animals; Benzazepines; Blood Proteins; Calcium Channel Blo

1985

Trials

15 trials available for verapamil and Aging

ArticleYear
P-glycoprotein function at the blood-brain barrier: effects of age and gender.
    Molecular imaging and biology, 2012, Volume: 14, Issue:6

    Topics: Adult; Aged; Aging; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Fe

2012
Effect of age on functional P-glycoprotein in the blood-brain barrier measured by use of (R)-[(11)C]verapamil and positron emission tomography.
    Clinical pharmacology and therapeutics, 2006, Volume: 79, Issue:6

    Topics: Adult; Aged; Aging; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood

2006
Pharmacokinetics of calcium blockers in patients with renal insufficiency and in geriatric patients.
    Acta medica Scandinavica. Supplementum, 1984, Volume: 681

    Topics: Administration, Oral; Adult; Aged; Aging; Diltiazem; Humans; Injections, Intravenous; Kinetics; Male

1984
Verapamil and norverapamil plasma levels in infants and children during chronic oral treatment.
    Therapeutic drug monitoring, 1995, Volume: 17, Issue:1

    Topics: Administration, Oral; Adolescent; Aging; Cardiomyopathy, Dilated; Child; Child, Preschool; Female; H

1995
Age-related changes of antianginal effects of verapamil in patients with stable effort angina. A medium term randomized double-blind placebo controlled trial.
    Giornale italiano di cardiologia, 1993, Volume: 23, Issue:5

    Topics: Adult; Aging; Angina Pectoris; Double-Blind Method; Exercise Test; Female; Humans; Male; Middle Aged

1993
Mixed-effect modeling for detection and evaluation of drug interactions: digoxin-quinidine and digoxin-verapamil combinations.
    Therapeutic drug monitoring, 1996, Volume: 18, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Aging; Anti-Arrhythmia Agents; Body Weight; Calcium Channel Blockers

1996
Gut wall metabolism of verapamil in older people: effects of rifampicin-mediated enzyme induction.
    British journal of clinical pharmacology, 1998, Volume: 45, Issue:3

    Topics: Aged; Aging; Biological Availability; Calcium Channel Blockers; Humans; Intestinal Mucosa; Male; Ref

1998
Exercise gas transport determinants in elderly normotensive and hypertensive humans.
    Experimental physiology, 1999, Volume: 84, Issue:1

    Topics: Adult; Aged; Aging; Biological Transport; Calcium Channel Blockers; Echocardiography, Doppler; Exerc

1999
Left ventricular diastolic filling and cardiovascular functional capacity in older men.
    Experimental physiology, 2000, Volume: 85, Issue:5

    Topics: Aged; Aging; Anaerobic Threshold; Blood Flow Velocity; Blood Pressure; Calcium Channel Blockers; Exe

2000
Effects of verapamil in normal elderly individuals with left ventricular diastolic dysfunction.
    Echocardiography (Mount Kisco, N.Y.), 2001, Volume: 18, Issue:2

    Topics: Aged; Aged, 80 and over; Aging; Calcium Channel Blockers; Cross-Over Studies; Diastole; Drug Adminis

2001
Left ventricular mass regression in elderly hypertensives.
    Journal of human hypertension, 1992, Volume: 6 Suppl 2

    Topics: Aging; Atenolol; Blood Pressure; Coronary Circulation; Delayed-Action Preparations; Echocardiography

1992
Low-dose verapamil in middle-aged and elderly patients with angina pectoris: no evidence of increased susceptibility to the cardiac effects.
    Cardiovascular drugs and therapy, 1992, Volume: 6, Issue:2

    Topics: Administration, Oral; Adult; Aged; Aging; Angina Pectoris; Blood Pressure; Female; Half-Life; Heart

1992
Special considerations in the elderly patient.
    Journal of human hypertension, 1990, Volume: 4 Suppl 5

    Topics: Age Factors; Aged; Aging; Atenolol; Blood Pressure; Cardiac Output; Cardiomegaly; Chlorthalidone; Do

1990
Treatment of isolated systolic hypertension in the elderly with verapamil slow-release 240 mg.
    Journal of cardiovascular pharmacology, 1989, Volume: 13 Suppl 4

    Topics: Aged; Aging; Blood Pressure; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Met

1989
The effects of age on the pharmacodynamics and pharmacokinetics of two formulations of verapamil.
    Journal of cardiovascular pharmacology, 1989, Volume: 13 Suppl 4

    Topics: Aged; Aging; Blood Pressure; Delayed-Action Preparations; Female; Humans; Hypertension; Male; Middle

1989

Other Studies

74 other studies available for verapamil and Aging

ArticleYear
Increased calcium channel in the lamina propria of aging rat.
    Aging, 2019, 10-31, Volume: 11, Issue:20

    Topics: Aging; Animals; Calcium Channel Blockers; Calcium Channels; Cell Line; Fibroblasts; Gene Expression

2019
Verapamil Prevents Development of Cognitive Impairment in an Aged Mouse Model of Sporadic Alzheimer's Disease.
    Molecular neurobiology, 2021, Volume: 58, Issue:7

    Topics: Aging; Alzheimer Disease; Animals; Brain; Calcium Channel Blockers; Cognitive Dysfunction; Disease M

2021
Effect of I
    Bulletin of experimental biology and medicine, 2016, Volume: 161, Issue:6

    Topics: Adrenergic alpha-Agonists; Age Factors; Aging; Animals; Animals, Newborn; Animals, Outbred Strains;

2016
Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PET.
    European journal of clinical pharmacology, 2009, Volume: 65, Issue:9

    Topics: Adult; Age Factors; Aged; Aging; Amygdala; ATP Binding Cassette Transporter, Subfamily B, Member 1;

2009
The aging heart: changes in the pharmacodynamic electrophysiological response to verapamil in aged rabbit hearts.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2010, Volume: 61, Issue:2

    Topics: Age Factors; Aging; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Carbachol; Electrop

2010
Assessment of pulmonary function and serum substance levels in newborn and juvenile rats.
    Reproductive toxicology (Elmsford, N.Y.), 2010, Volume: 30, Issue:3

    Topics: Administration, Inhalation; Aging; Animals; Animals, Newborn; Drug Evaluation, Preclinical; Drug-Rel

2010
Developmental changes in P-glycoprotein function in the blood-brain barrier of nonhuman primates: PET study with R-11C-verapamil and 11C-oseltamivir.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011, Volume: 52, Issue:6

    Topics: Aging; Animals; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Bra

2011
Age-related changes of P-glycoprotein-mediated rhodamine 123 efflux in normal human bone marrow hematopoietic stem cells.
    Leukemia, 2003, Volume: 17, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; ATP Binding Cassette Transporter, Subfamily B, Me

2003
Oleandrin produces changes in intracellular calcium levels in isolated cardiomyocytes: a real-time fluorescence imaging study comparing adult to neonatal cardiomyocytes.
    Journal of toxicology and environmental health. Part A, 2007, Mar-15, Volume: 70, Issue:6

    Topics: Aging; Animals; Animals, Newborn; Calcium; Calcium Channel Blockers; Cardenolides; Cells, Cultured;

2007
Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: a possible role in progressive neurodegeneration.
    Neurobiology of aging, 2009, Volume: 30, Issue:11

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Aging; ATP Binding Cassette Transporter, Su

2009
Comparative effects of verapamil, nifedipine, and diltiazem on contractile function in the isolated immature and adult rabbit heart.
    Pediatric research, 1984, Volume: 18, Issue:10

    Topics: Aging; Animals; Benzazepines; Calcium; Diltiazem; Dose-Response Relationship, Drug; Ion Channels; My

1984
Ventricular self-defibrillation in mammals: age and drug dependence.
    Age and ageing, 1980, Volume: 9, Issue:2

    Topics: Aging; Animals; Calcium Gluconate; Cats; Dibenzazepines; Drug Therapy, Combination; Electric Stimula

1980
The role of alkaline protease in the development of cardiac lesions in myopathic hamsters: effect of verapamil treatment.
    Biochemical medicine, 1984, Volume: 32, Issue:2

    Topics: Aging; Animals; Cardiomyopathies; Cricetinae; Endopeptidases; Female; Genes, Recessive; Muscles; Myo

1984
Transition from neurogenic to myogenic receptivity for thyrotropin-releasing hormone (TRH) in the duodenum of the neonatal rat.
    Endocrinology, 1981, Volume: 108, Issue:2

    Topics: Acetylcholine; Aging; Animal Population Groups; Animals; Animals, Newborn; Animals, Suckling; Duoden

1981
Early biochemical events associated with lymphocyte activation in ageing. I. Evidence that Ca2+ dependent processes induced by PHA are impaired.
    Immunology, 1981, Volume: 42, Issue:1

    Topics: Adult; Aged; Aging; Calcium; Cells, Cultured; Dose-Response Relationship, Immunologic; Edetic Acid;

1981
Prediction of steady-state verapamil plasma concentrations in children and adults.
    Clinical pharmacology and therapeutics, 1982, Volume: 32, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Aging; Child; Female; Humans; Infusions, Parenteral; Inject

1982
The electrophysiological properties of normal neonatal and adult canine cardiac Purkinje fibers.
    Circulation research, 1981, Volume: 48, Issue:5

    Topics: Action Potentials; Aging; Aminopyridines; Animals; Animals, Newborn; Dogs; Electric Stimulation; Ele

1981
The comparative electrophysiologic and hemodynamic effects of verapamil in puppies and adult dogs.
    Developmental pharmacology and therapeutics, 1981, Volume: 2, Issue:2

    Topics: Aging; Animals; Blood Pressure; Dogs; Electrophysiology; Heart; Heart Rate; Hemodynamics; Regional B

1981
Cholinergic regulation of [Ca2+]i during cell division and differentiation in the mammalian retina.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1995, Volume: 15, Issue:4

    Topics: Aging; Animals; Animals, Newborn; Calcium; Calcium Channel Blockers; Carbachol; Cell Differentiation

1995
Effect of acute smoking on red blood cell deformability in healthy young and elderly non-smokers, and effect of verapamil on age- and acute smoking-induced change in red blood cell deformability.
    Scandinavian journal of clinical and laboratory investigation, 1994, Volume: 54, Issue:6

    Topics: Adenosine Triphosphate; Adult; Aged; Aging; Erythrocyte Deformability; Humans; Male; Middle Aged; Sm

1994
Improvement of age-related impairment in left ventricular diastolic filling with verapamil in the normal human heart.
    Circulation, 1995, Feb-15, Volume: 91, Issue:4

    Topics: Aged; Aging; Diastole; Humans; Ventricular Function, Left; Verapamil

1995
Influence of autonomic blockade and aging on AV conduction and responses to verapamil in the beagle.
    The journals of gerontology. Series A, Biological sciences and medical sciences, 1995, Volume: 50, Issue:2

    Topics: Aging; Animals; Atrioventricular Node; Atropine; Autonomic Nervous System; Blood Pressure; Dogs; Dos

1995
Effect of calcium antagonists on isolated aorta from hypercholesterolemic Yoshida rats of different ages.
    General pharmacology, 1994, Volume: 25, Issue:7

    Topics: Aging; Animals; Aorta, Thoracic; Dinoprostone; Hypercholesterolemia; In Vitro Techniques; Male; Musc

1994
Verapamil stereoisomers during racemic verapamil administration: effects of aging and comparisons to administration of individual stereoisomers.
    Clinical pharmacology and therapeutics, 1994, Volume: 56, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Aging; Analysis of Variance; Female; Humans; Infusions, Intravenous;

1994
Improvement of the age-related impairment in left ventricular diastolic filling with verapamil in the normal human heart.
    Circulation, 1994, Volume: 90, Issue:1

    Topics: Adult; Aged; Aging; Blood Pressure; Coronary Circulation; Diastole; Female; Humans; Male; Middle Age

1994
Aging of women alters S-verapamil pharmacokinetics and pharmacodynamics.
    Clinical pharmacology and therapeutics, 1994, Volume: 55, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Aging; Female; Humans; Middle Aged; Stereoisomerism; Verapamil

1994
Influence of aging on the beta- and glucagon-receptor-mediated glycogenolysis in rat hepatocytes.
    Mechanisms of ageing and development, 1993, Aug-01, Volume: 70, Issue:1-2

    Topics: Aging; Animals; Calcium; Egtazic Acid; Enzyme Activation; In Vitro Techniques; Liver; Liver Glycogen

1993
Calcium-dependent efflux of K+ ions from stimulated T lymphocytes of young and old mice.
    Mechanisms of ageing and development, 1993, Oct-01, Volume: 71, Issue:1-2

    Topics: Aging; Animals; Calcimycin; Calcium; Concanavalin A; Female; Ionomycin; Male; Mice; Mice, Inbred BAL

1993
Stereoselective verapamil disposition and dynamics in aging during racemic verapamil administration.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 266, Issue:2

    Topics: Adult; Aged; Aging; Humans; Male; Metabolic Clearance Rate; Stereoisomerism; Verapamil

1993
The effects of age and gender on the stereoselective pharmacokinetics of verapamil.
    Clinical pharmacology and therapeutics, 1993, Volume: 54, Issue:3

    Topics: Adult; Aged; Aging; Analysis of Variance; Female; Half-Life; Humans; Male; Middle Aged; Sex Characte

1993
Early postnatal development of contractile performance and responsiveness to Ca2+, verapamil and ryanodine in the isolated rat heart.
    Journal of molecular and cellular cardiology, 1993, Volume: 25, Issue:6

    Topics: Aging; Animals; Calcium; Calcium Channels; Dose-Response Relationship, Drug; Heart; Male; Myocardial

1993
Aging effects on stereoselective pharmacokinetics and pharmacodynamics of verapamil.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 265, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Aging; Blood Pressure; Electrocardiography; Female; Heart Rate; Huma

1993
Developmental differences in cardiac myocyte calcium homeostasis after steady-state potassium depolarization: mechanisms and implications for cardioplegia.
    The Journal of pediatrics, 1993, Volume: 122, Issue:6

    Topics: Aging; Amiloride; Animals; Calcium; Cytosol; Electrophysiology; Fura-2; Heart; Heart Arrest, Induced

1993
The effects of verapamil and lidocaine on the duration of propofol and xylazine-ketamine anesthesia in broiler chickens.
    Veterinary and human toxicology, 1996, Volume: 38, Issue:3

    Topics: Aging; Analysis of Variance; Anesthesia; Anesthetics; Animals; Calcium Channel Blockers; Chickens; D

1996
Myocardial ultrasonic tissue characterization in pediatric and adult patients with hypertrophic cardiomyopathy.
    Circulation, 1996, Dec-01, Volume: 94, Issue:11

    Topics: Adult; Aging; Cardiomyopathy, Hypertrophic; Child; Child, Preschool; Echocardiography; Humans; Middl

1996
Quantification of Locusta diuretic hormone in the central nervous system and corpora cardiaca: influence of age and feeding status, and mechanism of release.
    Regulatory peptides, 1997, Mar-12, Volume: 69, Issue:1

    Topics: Aging; Animals; Calcium Channel Blockers; Central Nervous System; Chromatography, High Pressure Liqu

1997
The relaxing effect of BDF 9148 on the KCl-contracted aorta isolated from normo- and hyper-tensive rats.
    Naunyn-Schmiedeberg's archives of pharmacology, 1998, Volume: 357, Issue:2

    Topics: Aging; Animals; Aorta, Thoracic; Azetidines; Calcium Channel Blockers; Cardiotonic Agents; Electroph

1998
Involvement of angiotensin II in development of spontaneous nephrosis in Dahl salt-sensitive rats.
    European journal of pharmacology, 1998, Dec-04, Volume: 362, Issue:2-3

    Topics: Aging; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; B

1998
Verapamil metabolite exposure in older and younger men during steady-state oral verapamil administration.
    Drug metabolism and disposition: the biological fate of chemicals, 2000, Volume: 28, Issue:7

    Topics: Administration, Oral; Adult; Aged; Aging; Area Under Curve; Biotransformation; Humans; Male; Referen

2000
Pharmacokinetics of verapamil in New Zealand white rabbits during ontogeny.
    Biology of the neonate, 2000, Volume: 78, Issue:4

    Topics: Aging; Animals; Animals, Newborn; Kinetics; Liver; NADP; Oxidoreductases, N-Demethylating; Rabbits;

2000
Age-dependent variation in contractility of adult cardiac myocytes.
    The international journal of biochemistry & cell biology, 2001, Volume: 33, Issue:2

    Topics: Aging; Animals; Body Weight; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T

2001
Age-related changes in Purkinje fiber action potentials of adult dogs.
    Circulation research, 1978, Volume: 43, Issue:6

    Topics: Action Potentials; Aging; Animals; Carbamates; Dogs; Electrocardiography; Female; Heart Conduction S

1978
Density of 1,4-dihydropyridine receptors decreases in the hearts of aging hamsters.
    Journal of molecular and cellular cardiology, 1992, Volume: 24, Issue:8

    Topics: Aging; Allosteric Site; Animals; Calcium Channels; Cricetinae; Dihydropyridines; Diltiazem; In Vitro

1992
Measurements of intracellular calcium in sensory neurons of adult and old rats.
    Neuroscience, 1992, Volume: 50, Issue:4

    Topics: Aging; Animals; Calcium; Cytosol; Fluorometry; Fura-2; Ganglia, Spinal; Homeostasis; In Vitro Techni

1992
Cerebral vascular changes associated with hemorrhagic stroke in hypertension.
    Canadian journal of physiology and pharmacology, 1992, Volume: 70, Issue:4

    Topics: Aging; Animals; Cerebral Arteries; Cerebral Hemorrhage; Cerebrovascular Circulation; Cerebrovascular

1992
Age-related effects of ischemia, lidocaine and verapamil on overdrive-induced suppression of ventricular pacemakers in isolated rat heart.
    Aging (Milan, Italy), 1992, Volume: 4, Issue:2

    Topics: Aging; Animals; Coronary Disease; In Vitro Techniques; Lidocaine; Male; Rats; Rats, Inbred Strains;

1992
Aging and the response of the isolated perfused rat liver to vasoactive drugs.
    Biochemical pharmacology, 1992, Feb-18, Volume: 43, Issue:4

    Topics: Aging; Animals; Blood Flow Velocity; Blood Pressure; Female; Liver; Liver Circulation; Norepinephrin

1992
Differential age-dependent attenuation of reflex tachycardia by verapamil in rats.
    Mechanisms of ageing and development, 1991, Volume: 58, Issue:2-3

    Topics: Aging; Animals; Atropine; Female; Heart Rate; Nitroprusside; Parasympathetic Nervous System; Phenyle

1991
The influence of age on the pharmacokinetics of verapamil.
    Pharmacological research, 1991, Volume: 24, Issue:3

    Topics: Adult; Aged; Aging; Body Weight; Chromatography, High Pressure Liquid; Female; Half-Life; Humans; Hy

1991
[Beta-adrenoblockaders and calcium antagonists in the treatment of patients with ischemic heart disease combined with hypertension].
    Vrachebnoe delo, 1990, Issue:11

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Aging; Calcium Channel Blockers; Coronary Disease; Drug Ev

1990
The effects of aging on the electrophysiologic responses to verapamil in isolated perfused rat hearts.
    The Journal of pharmacology and experimental therapeutics, 1991, Jul-01, Volume: 258, Issue:1

    Topics: Aging; Animals; Drug Interactions; Electrophysiology; Heart Conduction System; Injections, Intraperi

1991
Aging alters verapamil elimination and dynamics: single dose and steady-state responses.
    The Journal of pharmacology and experimental therapeutics, 1990, Volume: 255, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Aging; Atrioventricular Node; Blood Pressure; Cold Temperature; Elec

1990
Effect of aging on calcium cytosolic concentration in rat cortical synaptosomes.
    Annali dell'Istituto superiore di sanita, 1990, Volume: 26, Issue:1

    Topics: Aging; Animals; Calcium; Cerebral Cortex; Cytosol; Male; Rats; Sodium; Synaptosomes; Verapamil

1990
Age-dependent increase in [3H]verapamil binding to rat cortical membranes.
    Neuroscience letters, 1985, Oct-24, Volume: 61, Issue:1-2

    Topics: Age Factors; Aging; Animals; Binding, Competitive; Calcium; Cerebral Cortex; Ion Channels; Male; Mem

1985
The prostaglandin response in guinea-pig taenia caeci and trachea smooth muscle of different ages.
    European journal of pharmacology, 1988, Mar-01, Volume: 147, Issue:2

    Topics: Aging; Animals; Carbachol; Cecum; Dinoprost; Dinoprostone; Guinea Pigs; In Vitro Techniques; Ion Cha

1988
Relationship between cytosolic free calcium concentration and 2-deoxyglucose uptake in adipocytes isolated from 2- and 12-month-old rats.
    Endocrinology, 1988, Volume: 122, Issue:6

    Topics: Adipose Tissue; Aging; Animals; Calcium; Cytosol; Deoxy Sugars; Deoxyglucose; Glyburide; Insulin; Io

1988
Treatment of mild to moderate hypertension with verapamil slow-release in outpatients. Collaborative Group of the Spanish League for the Fight Against Hypertension.
    Journal of cardiovascular pharmacology, 1989, Volume: 13 Suppl 4

    Topics: Aged; Aging; Blood Pressure; Delayed-Action Preparations; Female; Heart Rate; Humans; Hypertension;

1989
Effect of age and of hypertrophy on cardiac Ca2+ antagonist binding sites.
    Journal of cardiovascular pharmacology, 1989, Volume: 14, Issue:2

    Topics: Aging; Animals; Blood Pressure; Body Weight; Calcium Channels; Cardiomegaly; Cell Membrane; Dihydrop

1989
Verapamil disposition and cardiovascular effects in elderly patients after single intravenous and oral doses.
    Cardiovascular drugs and therapy, 1989, Volume: 3, Issue:3

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Aging; Blood Pressure; Electrocardiography; Fe

1989
Effect of age on K+-induced cytosolic Ca2+ changes in rat cortical synaptosomes.
    Journal of neurochemistry, 1989, Volume: 53, Issue:2

    Topics: Aging; Animals; Calcium; Cerebral Cortex; Cytosol; Fluorescence; Male; Microscopy, Electron; Potassi

1989
Age-related digoxin-verapamil interactions in the adult rat.
    Methods and findings in experimental and clinical pharmacology, 1989, Volume: 11, Issue:6

    Topics: Aging; Animals; Digoxin; Drug Interactions; Electrocardiography; Heart Rate; Male; Rats; Rats, Inbre

1989
The effects of aging on responses to verapamil in isolated right atria.
    Journal of gerontology, 1989, Volume: 44, Issue:6

    Topics: Aging; Animals; Atrial Function; Cardiac Pacing, Artificial; Dose-Response Relationship, Drug; Heart

1989
Calcium antagonists and hypertension.
    Clinical and experimental pharmacology & physiology, 1988, Volume: 15, Issue:2

    Topics: Aging; Aniline Compounds; Animals; Blood Pressure; Calcium Channel Blockers; Catecholamines; Dihydro

1988
Release of endogenous taurine and gamma-aminobutyric acid from brain slices from the adult and developing mouse.
    Journal of neurochemistry, 1989, Volume: 52, Issue:4

    Topics: Aging; Animals; Brain; Calcium; Female; gamma-Aminobutyric Acid; In Vitro Techniques; Magnesium; Mal

1989
[Clinical pharmacology of calcium antagonists].
    Schweizerische medizinische Wochenschrift, 1987, Mar-28, Volume: 117, Issue:13

    Topics: Aging; Arrhythmias, Cardiac; Biological Availability; Calcium Channel Blockers; Diltiazem; Drug Inte

1987
Verapamil and nifedipine effect on K+-induced contractions of guinea pig ileum during postnatal development.
    Developmental pharmacology and therapeutics, 1987, Volume: 10, Issue:6

    Topics: Aging; Animals; Female; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth;

1987
Physiological, pharmacological and pathological factors affecting the pharmacokinetics of calcium entry blockers.
    Giornale italiano di cardiologia, 1987, Volume: 17, Issue:9

    Topics: Aging; Animals; Calcium Channel Blockers; Diltiazem; Drug Administration Schedule; Guinea Pigs; Huma

1987
Age-dependent cardiovascular effects of verapamil in newborn swine.
    Pediatric research, 1986, Volume: 20, Issue:5

    Topics: Aging; Animals; Animals, Newborn; Blood Pressure; Heart Rate; Hemodynamics; Myocardial Contraction;

1986
Verapamil pharmacodynamics and disposition in young and elderly hypertensive patients. Altered electrocardiographic and hypotensive responses.
    Annals of internal medicine, 1986, Volume: 105, Issue:3

    Topics: Administration, Oral; Adult; Aged; Aging; Blood Pressure; Electrocardiography; Heart Rate; Humans; H

1986
Effects of verapamil on acetylcholine and field stimulation induced contraction in postnatal development of guinea-pig ileum.
    Research communications in chemical pathology and pharmacology, 1986, Volume: 53, Issue:2

    Topics: Acetylcholine; Aging; Animals; Electric Stimulation; Female; Guinea Pigs; Ileum; Male; Muscle Contra

1986
Ontogenetic differences in cardiac sensitivity to verapamil in rats.
    Pediatric cardiology, 1986, Volume: 7, Issue:1

    Topics: Aging; Animals; Animals, Newborn; Depression, Chemical; Dose-Response Relationship, Drug; Heart; In

1986
Age-related changes in the sensitivity to verapamil and sodium nitroprusside of vascular smooth muscle of rabbit aorta.
    British journal of pharmacology, 1985, Volume: 85, Issue:1

    Topics: Aging; Animals; Animals, Newborn; Aorta, Thoracic; Female; Ferricyanides; In Vitro Techniques; Male;

1985
Age-related changes in the pharmacodynamics of verapamil.
    American heart journal, 1985, Volume: 110, Issue:5

    Topics: Administration, Oral; Aging; Anesthesia; Animals; Blood Pressure; Dogs; Electrocardiography; Electro

1985
[Arrhythmias in the elderly patients: atrial fibrillation].
    Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 1985, Volume: 22, Issue:4

    Topics: Aged; Aging; Atrial Fibrillation; Coronary Disease; Diltiazem; Humans; Hypertension; Mitral Valve In

1985